复发性种植失败女性分泌中期子宫内膜中PECAM1介导的TGF-β1表达降低
这项前瞻性病例对照研究比较了复发性种植失败(RIF)女性与对照女性分泌中期子宫内膜中PECAM1和TGF-β1的表达,发现RIF组两者表达显著降低,体外实验显示PECAM1可调控TGF-β1,提示其可能参与子宫内膜容受性调节。
要点
- RIF组子宫内膜PECAM1 mRNA和蛋白水平显著低于对照组。
- RIF组TGF-β1表达亦显著降低,且PECAM1可调控TGF-β1表达。
- PECAM1和TGF-β1可能参与调节子宫内膜容受性。
核心结论
- RIF女性分泌中期子宫内膜中PECAM1和TGF-β1表达显著降低,可能参与胚胎种植失败。
研究设计与样本
- 前瞻性病例对照研究,RIF组22例(至少3次胚胎移植且累计至少4枚优质胚胎未妊娠),对照组18例(首个治疗周期妊娠)。
- 另取18例输卵管因素继发不孕女性,按早增生期、晚增生期和分泌中期分组,每组6例。
- 2017年12月从6例输卵管因素继发不孕女性采集原代子宫内膜上皮细胞和基质细胞。
主要发现
- 全基因组表达谱整合分析提示细胞黏附是RIF的关键调节因素。
- RIF组PECAM1 mRNA和蛋白水平显著低于对照组。
- 继发不孕女性月经周期中,PECAM1蛋白在早增生期最低,晚增生期略升高,分泌中期最高。
- RIF组TGF-β1表达显著降低。
- shRNA敲低PECAM1可显著降低Ishikawa细胞及原代HEECs和HESCs中TGF-β1表达。
局限性
- 作者指出,虽然已显示RIF女性中PECAM1和TGF-β1下调,但这些因子影响子宫内膜容受性的分子机制仍不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is recurrent implantation failure (RIF) associated with decreased expression of platelet and endothelial cell adhesion molecule 1 (PECAM1) and transforming growth factor β1 (TGF-β1) in the endometrium during the implantation window? SUMMARY ANSWER: The present study demonstrates that the expression of PECAM1 and TGF-β1 is significantly decreased in the mid-secretory endometrium in women with RIF, which may account for embryo implantation failure. WHAT IS KNOWN ALREADY: RIF has become a bottleneck issue that hampers the improvement of pregnancy rates in IVF-embryo transfer (IVF-ET). The causes of RIF are complex and may involve the dysregulation of various growth factors, metabolites, and inflammatory cytokines. At present, the precise pathogenesis of RIF has not been elucidated. STUDY DESIGN, SIZE, DURATION: This was a prospective case-control study. Endometrial tissue samples were obtained from January 2014 to December 2016 from two groups of women who had undergone IVF (RIF group, 22 women who underwent ≥3 ETs including a total of ≥4 good-quality embryos without pregnancy, control group, 18 women who conceived in their first treatment cycle). At the same time, samples were obtained from 18 women with infertility secondary to tubal factor in the early proliferative, late proliferative and mid-secretory phases of the menstrual cycle (n = 6 per group). Samples used for isolation of primary human endometrial epithelial cells and stromal cells (HEECs and HESCs) were collected in December 2017 from six women with infertility secondary to tubal factor. PARTICIPANTS/MATERIALS, SETTING, METHODS: We investigated gene expression using integrative whole genome expression microarray analysis, including differentially expressed gene screening, principal component analysis, and functional enrichment analysis. RT-qPCR, western blotting, immunohistochemistry, immunofluorescence co-localization analysis and short hairpin RNA (shRNA) plasmid transfection in Ishikawa cell line, HEECs and HESCs were used to investigate the expression of PECAM1 and TGF-β1. MAIN RESULTS AND THE ROLE OF CHANCE: Integrative data mining of whole-genome expression profiles identified cell adhesion as a key regulator in RIF. Database retrieval and literature review screened several novel cell adhesion-related genes that might participate in embryo implantation, which include PECAM1, intercellular adhesion molecule 2 (ICAM2), integrin subunit β2 (ITGB2), selectin P (SELP) and TEK receptor tyrosine kinase (TEK). Among these targets, the mRNA and protein levels of PECAM1 were significantly lower in the RIF group than those in the control group. During the menstrual cycles of women with secondary infertility, the protein expression level of PECAM1 was the lowest in early proliferative phase, slightly increased in late proliferative phase and was the highest in mid-secretory phase. While the expression level of HOXA10, an endometrial receptivity marker, kept at a low level in early proliferative phase and increased in late proliferative phase, then maintained at a high level in the mid-secretory phase. Furthermore, TGF-β1, mediated by PECAM1, was also decreased significantly in the RIF group. Using shRNA-based approach, we demonstrated that the depletion of PECAM1 significantly decreased the expression of TGF-β1 in Ishikawa cells, as well as in primary HEECs and HESCs. These results indicated that PECAM1 and TGF-β1 might play a pivotal role in modulating endometrial receptivity. LIMITATIONS REASONS FOR CAUTION: Although we have shown that PECAM1 and TGF-β1 were down-regulated in the women with RIF, the molecular mechanism of the effect of the factors on the endometrial receptivity remain unclear. WIDER IMPLICATIONS OF THE FINDINGS: Our findings provide insight into the contribution of PECAM1 and TGF-β1 in regulating implantation, which could be used to develop potential therapeutic methods for RIF. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from the National Natural Science Foundation of China (Nos. 81771656 and 81370763), Special fund for clinical research of the Chinese Medical Association (No. 16020480664), and the Merck Serono China Research Fund for Fertility Agreement. The authors have no competing interests.
引用
- Guo F, Si C, Zhou M, et al. Decreased PECAM1-mediated TGF-β1 expression in the mid-secretory endometrium in women with recurrent implantation failure. Hum Reprod. 2018. PMID: 29617817. doi:10.1093/humrep/dey022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。